Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Finke

Showing results (51-60 of 270) with videos related to

Pageof 27
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimensH Bertz, G Illerhaus, H Veelken, et al.
British Journal of Haematology|November 25, 1998
Successful adoptive immunotherapy for relapse of AML 9 years after T-cell-depleted BMTH Bertz, R Kunzman, D Bunjes, et al.
La Ricerca in Clinica E in Laboratorio|January 1, 1982
Solid-phase radioimmunoassays for Epstein-Barr virus associated antigensG Dölken, A Gier, J Finke, et al.
British Journal of Haematology|August 6, 2000
Incidence of mixed chimaerism and clinical outcome in 101 patients after myeloablative conditioning regimens and allogeneic stem cell transplantationR Wäsch, H Bertz, R Kunzmann, et al.
Cytokines and Molecular Therapy|March 1, 1996
Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell linesA Röth, P Pfaff, W Lange, et al.
Bone Marrow Transplantation|August 30, 2008
Long-term lymphoid-restricted split chimerism after myeloablative allogeneic BMT for bcr-abl+ ALLA Spyridonidis, H Bertz, M Waterhouse, et al.
Journal of Reproductive Immunology|August 1, 1987
The alloantibody response in the allogeneically pregnant rat. V. Absence of cell-mediated immunity in high respondersA Amsden, J Finke, N Coleman, et al.
European Journal of Clinical Investigation|November 9, 2004
Treatment with granulocyte colony-stimulating factor increases interleukin-1 receptor antagonist levels during engraftment following allogeneic stem-cell transplantationM Schwabe, A-M Hartert, H Bertz, et al.
Leukemia|November 1, 1993
In vitro and in vivo effects of synthetic ribozymes targeted against BCR/ABL mRNAW Lange, E M Cantin, J Finke, et al.
Der Nervenarzt|August 1, 1972
[Werner syndrome with neurologic-psychiatric symptoms]W Finke, U Spiegelberg, W Müller-Beissenhirtz, et al.
Pageof 27

Showing results (51-60 of 270) with videos related to

Sort By:
Pageof 27
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimensH Bertz, G Illerhaus, H Veelken, et al.
British Journal of Haematology|November 25, 1998
Successful adoptive immunotherapy for relapse of AML 9 years after T-cell-depleted BMTH Bertz, R Kunzman, D Bunjes, et al.
La Ricerca in Clinica E in Laboratorio|January 1, 1982
Solid-phase radioimmunoassays for Epstein-Barr virus associated antigensG Dölken, A Gier, J Finke, et al.
British Journal of Haematology|August 6, 2000
Incidence of mixed chimaerism and clinical outcome in 101 patients after myeloablative conditioning regimens and allogeneic stem cell transplantationR Wäsch, H Bertz, R Kunzmann, et al.
Cytokines and Molecular Therapy|March 1, 1996
Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell linesA Röth, P Pfaff, W Lange, et al.
Bone Marrow Transplantation|August 30, 2008
Long-term lymphoid-restricted split chimerism after myeloablative allogeneic BMT for bcr-abl+ ALLA Spyridonidis, H Bertz, M Waterhouse, et al.
Journal of Reproductive Immunology|August 1, 1987
The alloantibody response in the allogeneically pregnant rat. V. Absence of cell-mediated immunity in high respondersA Amsden, J Finke, N Coleman, et al.
European Journal of Clinical Investigation|November 9, 2004
Treatment with granulocyte colony-stimulating factor increases interleukin-1 receptor antagonist levels during engraftment following allogeneic stem-cell transplantationM Schwabe, A-M Hartert, H Bertz, et al.
Leukemia|November 1, 1993
In vitro and in vivo effects of synthetic ribozymes targeted against BCR/ABL mRNAW Lange, E M Cantin, J Finke, et al.
Der Nervenarzt|August 1, 1972
[Werner syndrome with neurologic-psychiatric symptoms]W Finke, U Spiegelberg, W Müller-Beissenhirtz, et al.
Pageof 27